The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia

Diagnostic Microbiology and Infectious Disease

Volumn 86, Issue 1, 2016, Pages 102-107

  Gilbert, David ^a   Gelfer, Gita ^a   Wang, Lian ^a   Myers, Jillian ^a   Bajema, Kristina ^a   Johnston, Michael ^a   Leggett, James ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

Community acquired pneumonia; Diagnostic bundles; FilmArray; Molecular diagnostics; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CALCITONIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSTICS; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY VIRUS; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TURNAROUND TIME; URINE CULTURE; VIRUS DETECTION; VIRUS PNEUMONIA; ADOLESCENT; BACTERIUM; BLOOD; CHEMISTRY; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; COMPARATIVE STUDY; DIAGNOSTIC TEST; DRUG EFFECTS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; NOSE MUCOSA; PNEUMONIA, BACTERIAL; PROCEDURES; RANDOMIZATION; SERUM; SPUTUM; TREATMENT OUTCOME; URINE; VERY ELDERLY; VIRUS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIA; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NASAL MUCOSA; PNEUMONIA, BACTERIAL; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; SERUM; SPUTUM; TREATMENT OUTCOME; VIRUSES; YOUNG ADULT;

EID: 84989842848     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.06.008     Document Type: Article

References (24)

1. Albrich, W.C., Madhi, S.A., Adrian, P.V., Telles, J.-N., Parankos-Baccala, G., Klugman, K.P., Genomic load from sputum samples and nasaopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults. J Clin Microbiol 52 (2014), 4224–4229.
2. Andrews, A.L., Simpson, A.N., Heine, D., Teufel, R.J., A cost-effectiveness analysis of obtaining blood cultures in children hospitalized for community-acquired pneumonia. J Pediatrics 167 (2015), 1280–1286.
3. Becker, K.L., Snider, R., Nylen, E.S., Procalcitonin assay in systemic inflammation, infection and sepsis: clinical utility and limitatons. Crit Care Med 36 (2008), 941–952.
4. Branche, A.R., Walsh, E.E., Vargas, R., Hulbert, B., Formica, M.A., Baran, A., et al. Serum procalcitonin and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis 212 (2015), 1692–1700.
5. Collins, A.M., Johnstone, C.M.K., Gritzfeld, J.F., Banyard, A., Hancock, C.A., wright AD et al. Pneumococcal colonization rates in patients admitted to a United kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control study. J. Clinical Microbiology 54 (2016), 944–949.
6. Falsey, A.R., Becker, K., Swinburne, A.J., Nylen, E.S., Formica, M.A., Hennessey, P.A., et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 208 (2013), 432–441.
7. Gadsby, N.J., Russell, C.D., McHugh, M.P., Mark, H., Morris, A.C., Lowenson, I.F., et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 62 (2016), 817–823.
8. Gelfer, G., Leggett, J., Myers, J., Wang, L., Gilbert, D.N., The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia. Diagn Microbiol Infect Dis 83 (2015), 400–406.
9. Gilbert, D.N., Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 52 (2011), S346–S350.
10. Gilbert, D.N., Where do we go from here (editorial). J Infect Dis 212 (2015), 1687–1689.
11. Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373 (2015), 415–427.
12. Janoff, E.N., Musher, D.M., Streptococcus pneumoniae. Bennett, J.E., Dolin, R., Blaser, M.J., (eds.) Principles and Practice of Infectious Diseases, 8th ed., 2015, Elsevier Saunders, Philadelphia, PA, 2310–2327.
13. Johansson, N., Kalin, M., Tiveljung-Lindell, A., Giske, C.G., Hedlund, F., Etiology of community-acquired pneumonia: increased yield with new diagnostic methods. Clin Infect Dis 50 (2010), 202–209.
14. Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (2007), S27–S72.
15. Musher, D.M., Roig, I.L., Cazares, G., Stager, C.E., Logan, N., Safar, H., Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 67 (2013), 11–18.
16. Que, Y.-A., Moreillon, P., Staphylococcus aureus. Bennett, J.E., Dolin, R., Blaser, M.J., (eds.) Principles and Practice of Infectious Diseases, 8th ed., 2015, Elsevier Saunders, Philadelphia, PA, 2237–2271.
17. Restrepo, M.I., Motensen, E.M., Velez, J.A., Frei, C., Anzueto, A., A comparative study of community-acquired pneumonia patients admitted to the ward and ICU. Chest 133 (2008), 610–617.
18. Said, M.A., Johnson, H.L., Nonyane, B.A., Deloria-Knoll, M., O'Brien, K.L., AGEDD Adult Pneumococcal Burden Study Team, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One, 8(4), 2013, e60273.
19. Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Douadma, L., Wolff, M., et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 55 (2012), 651–662.
20. Schuetz, P., Briel, M., Mueller, B., Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 309 (2013), 717–718.
21. Self, W.H., Williams, D.J., Zhu, Y., Ampofo, K., Pavia, A.T., Chappell, J.D., et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 213 (2016), 584–591.
22. Shibi, F., Chazan, B., Nitzan, O., Flatau, E., Edelstein, H., Blondheim, O., et al. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J 12 (2010), 477–482.
23. Spik, V.C., Beovic, B., Pokorn, M., Torkar, A.D., Vidmar, D., Papst, L., et al. Improvement of pneumococcal pneumonia diagnostics by the use of rt-PCR on plasma and respiratory samples. Scand J Infect Dis 45 (2013), 731–737.
24. van Deursen, A.M.M., van den Bergh, M.R., Sanders, E.A.M., Carriage of Streptococcus pneumoniae in asymptomatic community-dwelling elderly in the Netherlands. Vaccine 34 (2016), 4–6.